Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL, within 2 weeks of randomization
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL within 4 weeks before randomization
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Measured within 28 days prior to registration: absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count ? 1,500/mcL within 14 days of registration
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count ? 1,200/mcl
Absolute neutrophil count >= 1,500/mcL (>= 1,500/mm^3)
Absolute neutrophil count > 1500 cells/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 750/mcL (documented within 28 days of registration)
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
ENDOCRINE RESISTANT AND ADJUVANT COHORT: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL.
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count ? 1,500/mcL
Absolute neutrophil count ? 1,500 /mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
EXPANDED ACCESS COHORT: Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1.5 K/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count ?1,500/mcL
COHORT I: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,000/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count ? 1,500/mcL
Absolute neutrophil count >= 1,500/mcL.
Absolute neutrophil count >= 1,500/mcL.
Absolute neutrophil count ? 1000/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count at least 1,200/mcL
Neutrophil count of more than or equal to 1.0 x 10^9 cells/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL.
Absolute neutrophil count ? 1,000/mcL
Absolute neutrophil count < 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Within 28 days prior to administration of study treatment: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1000/mcL
Absolute neutrophil count >= 1,500/mcL
Within two weeks prior to enrollment: Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL.
Within 14 days of the first dose of the study drugs: Absolute neutrophil count >= 1000/mcL.
Absolute neutrophil count >= 750/mcL; >= 500/mcL if impairment is due to LPD/NHL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL within 30 days of registration
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL 14 days or fewer from registration
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL, assessed within 14 days prior to registration
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1500 mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
PHASE II: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 750/mcL
Absolute neutrophil count >= 1,500/mcL
Within 14 days prior to registration: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL, obtained within 14 days of first dose of drug
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcl
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count: >= 1,000/mcl
Absolute neutrophil count >= 750/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL.
Within 14 days of first dose of study drug administration: Absolute neutrophil count >= 1,500/mcL (1.5 x 10^9/L)
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count < 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 500 mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcl
Absolute neutrophil count >= 1,500/mcL, determined within 14 days of registration
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Within 4 weeks of preregistration: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1.5 K/mcL
Absolute neutrophil count >= 500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >1,500/mcL
Absolute neutrophil count ? 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
DOSE ESCALATION COHORT: Absolute neutrophil count ? 1,500/mcL
DOSE EXPANSION COHORT: Absolute neutrophil count ? 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1500/mcL
Within 28 days prior to administration of therapy: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,200/mcL
Step 2: Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 750 cells/mcL (0.75 x 10^9/L)
Absolute neutrophil count >= 1,000/mcL
Absolute lymphocytes count >= 500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
PHASE II: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,200/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL assessed within seven (7) days prior to the start of therapy
Absolute neutrophil count >= 1,500 mcl
Absolute neutrophil count > 500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
REGISTRATION #2 - PRIOR TO CONSOLIDATION CHEMOTHERAPY: Absolute neutrophil count >= 1,500 mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 750 cells/mcL (0.75 x 10^9/L)
Absolute neutrophil count > 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,800/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >=2000 per microliter (/mcL) and platelet count >=100,000/mcL;
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL, within 14 days of study registration
Absolute neutrophil count >= 1000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,000/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count greater than 1,500/mcL
Within 14 days of registration: Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
PHASE I: Absolute neutrophil count >= 1,500/mcL
PHASE II: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1.5 K/mcL
PART B: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count > 1,500/mcL
REGISTRATION INCLUSION CRITERIA: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1.5 K/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
absolute neutrophil count >1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute Neutrophil Count ? 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL within two weeks prior to enrollment
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,000/mcL
Neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,200/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,250/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count > 1,000/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1.5 K/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL (within four weeks prior to the study)
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count > 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,000/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,000/mcL
Neutrophil count >= 1000/mcL
Absolute neutrophil count >= 1,500/mcl
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1000/mcL
Absolute neutrophil count >= 1,000/mcL (measured within 2 weeks of registration)
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL (within 14 days of study registration)
Absolute neutrophil count ? 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count ? 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count > 1,500/mcL
Absolute neutrophil count >= 1,500/mcL
Peripheral absolute neutrophil count (ANC) >= 750/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL for patients with solid tumors without bone marrow involvement
Peripheral absolute neutrophil count (ANC) >= 750/uL for patients with solid tumors and known bone marrow metastatic disease
Peripheral absolute neutrophil count (ANC) >= 750/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) of at least 1,000/L
Peripheral absolute neutrophil count (ANC) >= 750/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Absolute peripheral neutrophil count (ANC) > 1,000.
Peripheral absolute neutrophil count (ANC) ?1.0 × 10^9/liter (L).
Peripheral absolute neutrophil count (ANC) >= 1500/uL
Peripheral absolute neutrophil count (ANC) >= 1,000/uL
Peripheral absolute neutrophil count (ANC) ? 750/uL
Peripheral absolute neutrophil count (ANC) >= 1500/uL
Peripheral absolute neutrophil count (ANC) >= 1,000/uL
Peripheral absolute neutrophil count (ANC) >= 1,000/uL
Peripheral absolute neutrophil count (ANC) > 1,000/uL
Peripheral absolute neutrophil count (ANC) >= 750/uL\r\n* If the ANC and/or platelet count are not adequate, but due to bone marrow metastatic disease, these criteria will be waived
For patients with solid tumors without bone marrow involvement: peripheral absolute neutrophil count (ANC) >= 1000/uL
For patients with solid tumors and known bone marrow metastatic disease: peripheral absolute neutrophil count (ANC) >= 750/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL (must not have received filgrastim [G-CSF] within the prior 7 days)
Peripheral absolute neutrophil count (ANC) >= 750/uL
Peripheral absolute neutrophil count (ANC) >= 1500/uL
The peripheral absolute neutrophil count must be at least 1,500/uL
Peripheral absolute neutrophil count (ANC) >= 750/m^3 (no transfusion within 7 days of enrollment)
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) >= 750/uL
Peripheral absolute neutrophil count (ANC) >= 1,000/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) >= 750/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) ? 1.5 x 109/L
Peripheral absolute neutrophil count (ANC) > 1,000/ul
Peripheral absolute neutrophil (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL (must not have received G-CSF [filgrastim] within the prior 7 days)
Must have absolute neutrophil count ? 1.5 x 10^9/L within 14 days prior to randomization.
Absolute neutrophil count ? 1,500/µL
Absolute neutrophil count >= 1.5 x 10^9/L.
Absolute neutrophil count < 1 x 10^9/L
Absolute neutrophil count > 1500/µL
Absolute neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count < 1.0 x 109/L
Absolute neutrophil count >= 1.5 x 10^9/L
Peripheral absolute neutrophil count ? 1.5 × 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count ?1.5 x 109/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 × 10^9/L
Absolute neutrophil count ?1500/µL.
Absolute neutrophil count >= 1.0 × 10^9/L
Absolute neutrophil count >= 1 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count > 1.5 x 10^9/L
Absolute neutrophil count >= institutional lower limit
absolute neutrophil count: ? 1.5 x 109/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count of >500/µL
Absolute neutrophil count >= 1.5 x 10^9/L, determined within 14 days of registration
Absolute neutrophil count < 1.5 x 109/L.
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count < 1.5 x 10 (exp9)/L
Absolute neutrophil count >= 1,000/mL
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count ?1.0×109/L
Neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count >= 750 prior to treatment
Neutrophil count >= 1.5 x 10^9/l
Absolute neutrophil count >= 1,000/dL
Absolute neutrophil count < 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count >= 1 X 10^9/L
Absolute neutrophil count <1.5 x 109/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count ? 1,500/?L
Absolute neutrophil count >= 1.2 x 10^9/L
Within 14 days of the first dose of study drug: Absolute neutrophil count >= 1,500/·L
Absolute neutrophil count of >= 1,500
Absolute neutrophil count >= 1,500
Absolute neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count >= 1500/mL.
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count levels < 0.5 × 10^9/L in the 4 weeks before screening
Absolute neutrophil count >= 1 x 10^9/L
Absolute neutrophil count < 500 at the time of enrollment
Neutrophil count >= 1000 prior to biopsy
Patients must have an absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count ? 1.5 × 10^9/L
Absolute neutrophil count < 1.0 x 10^9 /L
Absolute neutrophil count >= 1,500/mL
Absolute neutrophil count >= 1,000/dL
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count =< 1.5 x 10^9/L
Absolute neutrophil count ? 1500/?L
Absolute neutrophil count < 1 x 10^9/L
Absolute neutrophil count ?1.5 x 109/L;
absolute neutrophil count ? 1.5x10^9/L
Absolute neutrophil count > 500 mL
Absolute neutrophil count >= 1000/?l
Absolute neutrophil count >= 1.5 × 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count of < 1.0 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
absolute neutrophil count ? 1.5 x 10^9/L
Absolute neutrophil count >= 1,500/µL
Absolute neutrophil count more or equal to 750/mL
Absolute neutrophil count >= 1,000/mL
Absolute neutrophil count >= 1000/mL
Absolute neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count >= 1,500/mL
Absolute neutrophil count < 1.5 x 10^9/L
Absolute neutrophil count >= 0.5 x 10^9/L
Neutrophil count of > 1,500/mL
Absolute neutrophil count ? 1,500/µL
absolute neutrophil count ? 1000/?L,
Absolute neutrophil count ? 1500/?L
Neutrophil count >= 1.5 x 10^9/l
Absolute neutrophil count >= 1500/mL
Absolute neutrophil count >= 1500/mL
Neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1,500
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count <1.0 × 10^9/L.
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 × 10^9/L
Absolute neutrophil count >= 1.5 × 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1500/mL
Neutrophil count < 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count ? 1000/µL
Neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
absolute neutrophil count >750/µL
Absolute neutrophil count ? 1.0 X 10 9/L,
Absolute neutrophil count ? 1.5 x 10^9/L
absolute neutrophil count ?1.5 × 109/L
Absolute neutrophil count ? 1.5 x 10^9/L
Absolute neutrophil count ? 1.5 x 10^9/L
Absolute neutrophil count >= 1,500/L
Absolute neutrophil count >= 1.0 x 10^ 9/L
Absolute neutrophil count ? 1.5 x 106/µl
Absolute neutrophil count < 1.0 x 10^9/L
Absolute neutrophil count > 1000/?L
Absolute neutrophil count >= 1.5 x 109/L.
Absolute neutrophil count >= 1.0 x 10^9/L
Neutrophil count: ? 1.5 x 109/L
Absolute neutrophil count ? 1.5 × 109/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1500/mL
Absolute neutrophil count >= 1.0 x 10^9/L
Absolute neutrophil count >= 1,500/?L
Absolute neutrophil count ?1,500/µL and
Absolute neutrophil count >= 1,500
Absolute neutrophil count >=1.5 x 10^9/litre (L)
Absolute neutrophil count =< 1.5 x 10^9/L
Absolute neutrophil count >=1500/mL
Absolute neutrophil count ?1500/?L
Absolute neutrophil count >= 1,000/mL
Absolute neutrophil count ?1.5 ×109/L;
Absolute neutrophil count >= 1,500/mL
Absolute neutrophil count ? 1.5 x 10^9/L.
Absolute neutrophil count >= 1,000/dL
Absolute neutrophil count > 1200
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count < or equal to 1.5 x 10^9/L
Absolute neutrophil count ? 1.5 x 10^9/L.
Absolute neutrophil count >= 1,000/mL
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1.2 x 10^9/L
Neutrophil count >= 1.5 x 10^9/l
Absolute neutrophil count >= .750 x 10^9/L
Neutrophil < 1.0 x 10^9/L
Patient has an absolute neutrophil count of < 1000 within 5 days before enrollment
Absolute neutrophil count >= 1,000 (1.0 x 10^9/L)
Absolute neutrophil count >= 1,000/mL
Absolute neutrophil count >= 1.5 x 10^9/L
Neutrophil count >= 1000 prior to biopsy
Absolute neutrophil count >= 1,500
Absolute neutrophil count < 500 at the time of brachytherapy
Has an absolute neutrophil count <1.0x10^9/L within 14 days before enrollment
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1,000/mL
Absolute neutrophil count >= 1.0 x 109/L
Absolute neutrophil count >= 1,000/mL
SORAFENIB ARM: absolute neutrophil count >= 1,000/mL
Patient has an absolute neutrophil count of less 1000 within 14 days before enrollment
Absolute neutrophil count ?1.5 x 109/L,
Absolute neutrophil count >= 1,000/mL
Patient has an absolute neutrophil count of < 1.2 x 10^9/L.
Absolute Neutrophil Count of at least 1.5 x 109/L
Absolute Neutrophil Count 75 x 10(9)/L;
Absolute neutrophil count >= 1.5 x 10^9/L
Evidence of myeloid engraftment (absolute neutrophil count ?0.5 x 10^9/L)
Absolute neutrophil count ?1,000/?L
Absolute neutrophil count ? 1,000/?L;
Absolute neutrophil count of > 1.5 x 10^9/L
Absolute neutrophil count of >= 1.2 x 10^9/L
Absolute neutrophil count >= 1.2 x 10^9/L
Absolute neutrophil count >= 1,500/microliters
Absolute neutrophil count ?1,500/?L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count <1000/mL
Absolute neutrophil count >= 1,500/microliters
Absolute neutrophil count <1.5 x 10^9/L.
Absolute neutrophil count ? 1.5 x 10^9/L within 14 days prior to randomization.
Absolute neutrophil count of 1500 or greater
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count at least 1.5 x 10^9/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count >= 1,500/?L
Absolute neutrophil count >= 1,000/mL
Absolute neutrophil count >= 1,200/µL
Absolute Neutrophil Count < 1.000/µl.
Absolute neutrophil count ? 1.0 × 10^9/L within 21 days prior to randomization
Absolute neutrophil count >= 1,500/mL
Absolute neutrophil count within institutional normal limits
Neutrophil count of >= 0.5 x 10^9/L
Absolute neutrophil count of at least 1.5 × 109/L,
Absolute neutrophil count >= 1,500
Absolute neutrophil count <1000/mL
Patient currently with neutropenia (absolute neutrophil count <1000) within 6 weeks screening
Absolute neutrophil count ³ 1.5 x 109/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count ?1.50 x 109/L
Absolute neutrophil count >= 1.5 x 10^9/L
Absolute neutrophil count > 750
Absolute neutrophil count > 1,500/µL
Absolute neutrophil count >= 1.5 x 10^9/L
Neutrophil count <1.5 x 109/L
Absolute neutrophil count < 1.0 x 10^9/L
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count > 1000 /uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/ul
Absolute neutrophil count >= 1.5 K/uL
Absolute neutrophil count ? 1,000/ul
Absolute neutrophil count 1500/ul or more
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1.5 K/uL
Absolute neutrophil count >= 1.5 K/uL
Absolute neutrophil count >= 1.5 K/uL
Absolute neutrophil count >= 1.5 K/uL within 14 days prior to start of protocol therapy.
Absolute neutrophil count ? 1.5 K/uL
PHASE I: Absolute neutrophil count >= 1500/uL
PHASE IB: Absolute neutrophil count >= 1500/uL
Absolute neutrophil count >= 1000 cells/uL
INCLUSION CRITERIA FOR STRATUM C: Absolute neutrophil count >= 1000 cells/uL
Absolute neutrophil count < 1,000/uL
Absolute neutrophil count >= 1500/uL
Absolute neutrophil count =< 1,500/uL
Absolute neutrophil count >= 1.0 K/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count ? 500/uL
Absolute neutrophil count >= 500 /uL
Absolute neutrophil count ? 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 750 cells/uL
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count >= 1,500 cells/uL
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count 1500/ul or more
Absolute neutrophil count < 1000/uL at the screening visit
Absolute neutrophil count 1500/ul or more
Absolute neutrophil count >= 1,500/uL.
Absolute neutrophil count >= 1.5 K/UL
Absolute neutrophil count > 1.5 K/uL
Absolute neutrophil count >= 1500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL.
Absolute neutrophil count >= 750/uL
Absolute neutrophil count >= 1500/uL
No more than 14 days prior to registration: Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500 uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count > 750 cells/uL
Absolute neutrophil count >= 1,200/uL
Absolute neutrophil count >= 1,500 /uL
Neutrophil count >= 1000/uL prior to biopsy
Neutrophil count >= 1500 uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count ?1000/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL within 14 days prior to study entry
Absolute neutrophil count >= 1200/uL performed within 7 days of treatment initiation
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count > 1,500 uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= to 1,500 /uL
Absolute neutrophil count >= 1,000/uL within 30 days prior to course 1 day 1 (C1D1)
Absolute neutrophil count >= 1,200/ul
Absolute neutrophil count >= 1,500/uL obtained within 14 days of first treatment
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count < 1500/uL
Absolute CD4 count > 200 cells/uL
Absolute neutrophil count >= 500/ul
ARM A COHORT 1: Absolute neutrophil count >= 1,500/ul
ARM B COHORT 2: Absolute neutrophil count >= 1,500/ul
ARM B COHORT 3: Absolute neutrophil count >= 1,500/ul
ARM C COHORT 4: Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count > 1,000/ul
Absolute neutrophil count >= 1,500/uL within 14 days of the first dose of study drug
Absolute neutrophil count >= 1.5 k/uL
Absolute neutrophil count >= 1500/uL
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count >= 1,000/uL (within 2 weeks prior to radiotherapy)
Absolute neutrophil count >= 500/ul (phase I only)
Absolute neutrophil count >= 1500/uL
Neutrophil count >= 1000 /uL
Absolute neutrophil count >= 500/ul
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count > 1,500/uL during screening evaluation
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count >= 1,500/uL
TUMOR BIOPSY SEQUENCING: Absolute neutrophil count >= 1,000/uL (mcL)
TREATMENT: Absolute neutrophil count >= 1,000/uL (mcL)
Absolute neutrophil count 1500/ul or more
Neutrophil count >= 1,500/ul
Secondary Registration: absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count: >= 1,500/ul
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Performed within 14 days of patient registration: Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1500/ul
Absolute neutrophil count >= 1,500/ul
Absolute Lymphocytes ?800/uL
Absolute neutrophil count/absolute granulocyte count ?1500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1000/uL
Absolute neutrophil > 1000/uL
Absolute neutrophil count >= 1,000/ul
Absolute neutrophil count: >=1,000/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1500 /uL
Within 14 days prior to registration: absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL obtained =< 7 days prior to randomization
Absolute neutrophil count >= 1.0 K/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,000/ul
Absolute neutrophil count < 1,000/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 1,000/uL
Neutropenia (absolute neutrophil count < 1 x 10^3/uL)
Absolute neutrophil count >= 1000/uL
Absolute neutrophil count >= 500/ul
Absolute neutrophil count >= 1.5 K/UL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count < 1,500/uL
Absolute neutrophil count >= 500/ul
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500 cells per uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1000/uL
Absolute neutrophil count >= 1,500/uL
Neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500/uL, within 14 days of registration
Absolute neutrophil count >= 1.5/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1500/uL
Absolute neutrophil count >= 1000/uL
Absolute neutrophil count >= 1500/uL within 30 days prior to registration
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1000 uL
Absolute neutrophil count > 1,500/ul
Absolute neutrophil count of > 1000/ul
Neutropenia (absolute neutrophil count < 1 x 10^3/uL)
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 750 cells/uL
Absolute neutrophil count 1,500/uL
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count > 1000/uL
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500/ul
Absolute neutrophil count >= 1,500 cells/uL
Absolute neutrophil count >= 1000uL
Absolute neutrophil count >= 1000/uL
Absolute neutrophil count > 1000/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1500/ul
Absolute neutrophil count >= 1,500/ul
Abnormal marrow function as defined as absolute neutrophil count <1,500/ul or platelets <100,000/ul.
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 500/ul
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count < 1500/uL
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1500/uL
Absolute neutrophil count >= 1500/uL
Absolute neutrophil count >= 1,000/uL
Absolute neutrophil count >= 1,500/uL
Neutrophil count >= 1,200/mm^3 (>= 1.2 k/uL)
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count > 1,000/uL
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count > 1000/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,200/ul
Absolute neutrophil count (ANC) >= 1,500/uL, obtained within 4 weeks prior to randomization
Absolute neutrophil count (ANC) >= 750/uL (>= 0.75 X 10^9/L), within 14 days of registration
Absolute neutrophil count (ANC) >= 1250/ul
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1500/uL, within 14 days of registration
Absolute neutrophil count (ANC) ? 1500/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 750/uL
Absolute neutrophil count (ANC) ? 1000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,500 cells/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) ? 1,500/uL within 28 days prior to registration
Absolute neutrophil count (ANC) > 1500 cells/uL
Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,500 cells/ul
INCLUSION - TREATMENT: Absolute neutrophil count (ANC) >500/ul
Absolute neutrophil count (ANC) >= 1,500 cells/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL.
Absolute neutrophil count (ANC) >= 1000 cells/uL
Neutropenia (absolute neutrophil count [ANC] < 1000 cells/ul)
Absolute neutrophil count (ANC) >= 1500 cells/uL.
Absolute neutrophil count (ANC) < 1,500/uL
Absolute neutrophil count (ANC) > 1,000/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) > 1,000/uL.
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1.5 k/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/ uL, within 2 weeks of registration
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 /uL)
Absolute neutrophil count (ANC) > 1000/ul
Absolute neutrophil count (ANC) >= 1500 ul
Absolute neutrophil count (ANC) >= 1500 ul.
Absolute neutrophil count (ANC) > 1000/uL
Absolute neutrophil count (ANC) >= 1,000 cells/uL
Absolute neutrophil count (ANC) > 1 K/uL.
ANC (Absolute neutrophil count) >= 1000/ul (unsupported)
Absolute neutrophil count (ANC) 1.0 x 10^9/L (1,000/uL)
Absolute neutrophil count (ANC) >= 1,500 cells/ul (prior to biopsy)
Absolute neutrophil count (ANC) >= 1,500/uL
Within 28 days prior to enrollment: Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) of >= 1,000/uL
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) < 500/uL
Absolute neutrophil count (ANC) >= 1500/ul within 14 days of cycle 1 day 1
absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) > 1,000/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1,500/ uL, within 2 weeks of registration (except where specified otherwise)
Absolute neutrophil count [ANC] >= 1500 cells/uL
Absolute neutrophil count (ANC) =< 1,000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Patients must have an absolute neutrophil count (ANC) greater than or equal to 1500/uL
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) < 1500 cells/uL
Within 14 days of registration: Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) >= 1500/uL; filgrastim can be given before and during treatment to achieve target ANC >= 1500 uL
Absolute neutrophil count (ANC) >= 1,500/uL (performed within 28 days of registration)
Absolute neutrophil count (ANC) > 1000/uL should be obtained within 21 days prior to enrollment
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1000/uL at screening visit
Absolute neutrophil count (ANC) > 1000/uL
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Recovery from induction therapy (absolute neutrophil count [ANC] > 200/ul, platelet count > 20,000/ul)
Absolute neutrophil count (ANC) < 200/ul prior to treatment
Absolute neutrophil count (ANC) > 1000/uL
Patients must have absolute neutrophil count (ANC) >= 1000/uL; neupogen can be given before and during treatment to achieve target ANC >= 1000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) should be > 500/uL
Absolute neutrophil count (ANC) > 1000/uL
Absolute neutrophil count (ANC) >= 1,000 cells/ul
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) >= 1000/uL
Within 3 months of registration: Absolute neutrophil count (ANC) >= 1000 cells/uL
Within 14 days prior to study entry: Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1500 cells/ul
Absolute neutrophil count (ANC) > 1,000/ul
Must be met within 28 days of C1D1: Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) of >= 1000/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,500/uL, performed within 28 days prior to registration
Absolute neutrophil count (ANC) >= 1,500 cells/ul
Absolute neutrophil count (ANC) < 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) greater than 500/uL
Absolute neutrophil count (ANC) >= 1.5 x 10 (3)uL
Absolute neutrophil count (ANC) >= 1,500 cells/ul
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1000 cells/uL
Absolute neutrophil count (ANC) >= 1000/ul
Absolute neutrophil count (ANC) >= 1,000 cells/uL
Absolute neutrophil count (ANC) > 1,000/ul
Absolute neutrophil count (ANC) > 1500/uL
Absolute neutrophil count (ANC) >= 1500 uL
Absolute neutrophil count (ANC) > 1,000/uL
Absolute neutrophil count (ANC) >= 1,500 /uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) =< 1000/ul
Absolute neutrophil count (ANC) > 1,000/ul
Absolute neutrophil count (ANC) >= 1,000/ul
Full hematologic recovery following Auto HCT including:\r\n* Absolute neutrophil count (ANC) >1000 ul\r\n* Platelet count of >= 50,000 ul independent of transfusion for >7 days
Absolute neutrophil count (ANC) >= 1,500/ul within 7 days prior to starting treatment
Absolute neutrophil count (ANC) > 1,500/uL
Patients must have an absolute neutrophil count (ANC) > 1000/ul and a platelet count > 50,000/ul
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500 cells/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,000/ul
Absolute neutrophil count (ANC) > 1,500/uL
Patients must have absolute neutrophil count (ANC) > 1000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) => 1500/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500 cells/uL
Within 14 days of subject registration: Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) > 1,500/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) > 1500/uL
Absolute neutrophil count (ANC) >= 1,000 cells/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000/ul
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) > 1,000/ul
Absolute neutrophil count (ANC) > 1,500/ul
Neutropenia (absolute neutrophil count [ANC] < 1000 cells/ul)
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) ? 1000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >=1500/microlitre (uL).
Absolute neutrophil count (ANC) > 1,500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) > 750/uL
Absolute neutrophil count (ANC) should be > 500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) > 1000 K/uL independent of transfusion support
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) > 1500/uL
Within 4 weeks of administration of study therapy: Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) > 1000 uL
Absolute neutrophil count (ANC) > 1500/ul
Absolute neutrophil count (ANC) < 1,000/ul
Absolute neutrophil count (ANC) >= 1,500 cells/ul
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000/ul
Absolute neutrophil count (ANC) >= 1,500 cells/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 750 cells/uL within 14 days before enrollment
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) > 1000/uL
AT THE TIME OF INFUSION: Absolute neutrophil count (ANC) > 750/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1500/uL
Adequate bone marrow function (Absolute neutrophil count (ANC) ? 1,500 cells/uL; Platelets (PLT) ? 100,000 cells/uL)
COHORT A: Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1000/ul (unsupported)
Absolute neutrophil count (ANC) greater than or equal to 1500/uL
Absolute neutrophil count (ANC) >= 1500 / uL
Absolute neutrophil count (ANC) >= 1000/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,200/ul
Absolute neutrophil count (ANC) >= 750 cells/uL (0.75 x 10^9/L)
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) or absolute granulocyte count (AGC) >= 1500 per uL
Absolute neutrophil count (ANC) of less than 250 cells/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) =< 1500/uL
Absolute neutrophil count (ANC) >= 750/uL
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) < 1,500 /uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500 cells/uL
Within 14 days after subjects signed the treatment consent: Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC): >= 1000/uL (~ 1 x 10^9/L)
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Patients must have an absolute neutrophil count (ANC) >= 500/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1,000/ul
Absolute neutrophil count (ANC) >= 1000/uL
Within 14 days prior to enrollment/randomization: Absolute neutrophil count (ANC) > 1.5 K/uL
Absolute neutrophil count (ANC) >= 1.0 K/uL
Absolute neutrophil count (ANC) >= 1,500 cells/ul
Absolute neutrophil count (ANC) >= 1,500/ul (unless low ANC is due to multiple myeloma)
Absolute neutrophil count (ANC) > 1500/ul
Absolute neutrophil count (ANC) =< 1,500 cells/ul
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) > 1000/ul
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) > 1,000 cells/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) > 1,500/uL
Absolute neutrophil count (ANC): >= 1000/uL (~0.5 x 10^9/L)
Absolute neutrophil count (ANC) must be >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/ul
Absolute neutrophil count (ANC) >= 1000/ul
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC): >= 1,500/ul
Absolute neutrophil count (ANC) > 1,000/ ul 3
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/ uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute Neutrophil Count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1000/ul
Absolute neutrophil count (ANC) >= 1500/uL
An absolute neutrophil count (ANC) > 1500/ul
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) > 1000/uL not supported by transfusions
Absolute neutrophil count (ANC) > 1.5 K/uL
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1200/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) > 1500/uL
Absolut neutrophil count (ANC) > 1500/uL
Absolute neutrophil count (ANC) >= 1,000/uL
Absolute neutrophil count (ANC) > l500/ul
Absolute neutrophil count (ANC) > 1500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >=1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Have documented lab work with absolute neutrophil count (ANC) >= 1.0 K/uL and platelets >= 50 K/uL in the past 12 months
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) > 1,000 cells/ul
Absolute neutrophil count (ANC) > 1500/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) < 1,500 K/UL in the past 30 days
Absolute neutrophil count (ANC) greater than 500/uL
Absolute neutrophil count (ANC) < 1,500 K/UL in the past 30 days
Neutropenia (serum absolute neutrophil count [ANC] < 1,000/uL)
Within 30 days of eligibility confirmation: Absolute neutrophil count (ANC) >= 1,500 uL
Absolute neutrophil count (ANC) ? 1000/uL
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) > 1500 cells/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1000 cells/uL
Absolute neutrophil count (ANC) > 1500/ul
Absolute neutrophil count (ANC) ? 750/uL
Absolute neutrophil count (ANC) ?1500/mm3 (?1.5 × 103/uL)
Absolute neutrophil count (ANC) >= 1 x 10^9/L within 30 days of day 1 of study
Absolute neutrophil count (ANC) >= 1.5 10^9/L, within 28 days prior to administration of study treatment
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L measured within 28 days prior to randomization
Absolute neutrophil count >= 1500/uL; Note: no transfusions are permitted 7 days prior to laboratory studies to determine eligibility
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L, measured within 28 days prior to administration of study treatment
Absolute neutrophil count (ANC) >= 1,500/ul without the use of hematopoietic growth factors (within 14 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1,500/mm^3 (1.5 x 10^9/L) must be met within 28 days of cycle 1 day 1 (C1D1)
Absolute neutrophil count (ANC) >= 1.5 X 10^9/L within 14 days of starting cycle 1 day 1 treatment
Within 10 (except as noted) days of planned treatment initiation: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (>= 1500 per mm^3)
Absolute neutrophil count (ANC) >= 1500/uL performed within 30 days prior to the date of registration
Absolute neutrophil count >= 1,500/microliters, completed within 14 days prior to the date of registration
Within 28 days of study registration: Absolute neutrophil (segmented and bands) count (ANC) >= 1.0 x 10^9/L
Absolute neutrophil count (ANC) >= 1,500/uL within 14 days prior to first dose of protocol-indicated treatment.
Absolute neutrophil count (ANC) < 1000/mm^3, per principal investigator (PI) discretion if thought to be related to underlying myeloma
Within 10 days prior to the start of study treatment: Absolute neutrophil count (ANC) >= 1500/uL
Within 7 days of enrollment and with 24 hours (h) of starting lymphodepleting chemotherapy: Absolute neutrophil count (ANC) >= 1000/mm^3.
Absolute neutrophil count (ANC) >= 1,000/mm^3, performed within 14 days prior to day 1 of protocol therapy\r\n* Filgrastim can be given prior to enrollment to achieve target ANC >= 1000/uL
Within 28 days prior to treatment start: Absolute neutrophil count (ANC) >= 1500/ul
Obtained within 21 days prior to cycle 1, day 1: absolute neutrophil count (ANC) >= 1 x 10^9/L
Absolute neutrophil count (ANC) > 1.5 k/cumm
STUDY TREATMENT: Absolute neutrophil count (ANC) >= 1500 cells/uL within 14 days prior to the first study treatment.
Obtained within 14 days of the first study treatment: Absolute neutrophil count (ANC) > 1500 cells/ul
Absolute neutrophil count (ANC) > 1,000/uL unless disease-related (due to marrow infiltration or splenomegaly)
Within 7 days prior to administration of study treatment: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (unless due to bone marrow infiltration by tumor, in which case ANC > 1,000/mm^3 is allowed).
Absolute neutrophil count (ANC) >= 1,000 cells/mm^3 (1.0 x 10^9/L) must be met during screening (within 21 days) and also prior to study drug administration on cycle 1 day 1
Obtained within 14 days of the first study treatment: Absolute neutrophil count (ANC) > 1500 cells/ul
Within 7 days (+ 3 day window) of enrollment: Absolute neutrophil count (ANC) >= 1.0 x 10^9/L (> 1000 per mm^3)
Obtained within 14 days prior to the first study treatment (cycle 1, day 1): absolute neutrophil count (ANC) >= 1500 cells/u
Within 14 days of the first study treatment: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
Absolute neutrophil count (ANC) ?1500/millimeters cubed (mm^3) (?1.5 × 10^3/microliters [µL])
Within 14 days prior to cycle 1 day 1 of treatment: Absolute neutrophil count (ANC) >= 1,000 K/mm^3
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L, measured within 28 days prior to administration of study treatment
Subjects with an absolute neutrophil count (ANC) of equal to or higher than 0.5 x 10^9 at the screening visit
Within 14 days prior to the first study treatment (cycle 1, day 1): Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute neutrophil count (ANC) >= 1000/uL, within 14 days of study registration (within 30 days for pulmonary and cardiac assessments)
Absolute neutrophil count (ANC) >= 1500 cells/uL (obtained within 28 days prior to first study treatment)
Absolute neutrophil count (ANC) ? 1500 cells/uL within 14 days prior to the first study treatment (cycle 1, day 1)
To be performed within 10 business days prior to day 1: Absolute neutrophil count (ANC) >= 1,000/mm^3; filgrastim can be given prior to enrollment to achieve target ANC >= 1000/uL
Absolute neutrophil count (ANC) >= 1.5 X 10^9/L, within 14 days start of study start
Absolute neutrophil count (ANC) < 1000/mm^3 unless lymphoma, KSHV-MCD, or KICS-related
Absolute neutrophil count (ANC) >= 1.0 x 10^9/L\r\n* By automated or manual review, whichever is greatest
Absolute neutrophil count (ANC) or atypical glandular cell (AGC) >= 1500 per uL
Absolute neutrophil count (ANC) < 1,000/mm^3 (Unit of International System of Units [SI] units 109/L)
Absolute neutrophil count (ANC) >= 1 x 10^9 (International System [SI] units 10^9/L) (with or without filgrastim [G-CSF])
Absolute neutrophil count (ANC) >= 1.5 K/CUMM
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (measured within 28 days prior to administration of study treatment)
INCLUSION CRITERIA FOR ADDITIONAL PTCy-MILs INFUSION AT RELAPSE: Absolute neutrophil count (ANC) >= 1,500/uL
TREATMENT: Engrafted post-transplant (absolute neutrophil count [ANC] > 500 for at least 3 consecutive days) and ANC > 500 at the time of infusion
Evidence of neutrophil engraftment defined as the absolute neutrophil count (ANC) > 0.5 x 10^3/for 3 consecutive days
Absolute neutrophil count >= 1,500/uL obtained no more than 28 days prior to the start of neoadjuvant endocrine therapy
Absolute neutrophil count >= 1,500 cells/uL (to be performed within 7 days prior to start of study treatment)
Absolute neutrophil count (ANC) >= 1.0 x 10^9/L within 14 days prior to starting therapy
Treatment indicated based on demonstration of at least one of the following no more than 4 weeks from the time of enrollment, and no less than 6 months after prior cladribine and no less than 4 weeks after other prior treatment, if applicable:\r\n* Neutropenia (absolute neutrophil count [ANC] < 1000 cells/ul)\r\n* Anemia (hemoglobin [Hgb] < 10g/dL)\r\n* Thrombocytopenia (platelets [Plt] < 100,000/ul)\r\n* Absolute lymphocyte count (ALC) of > 5,000 cells/uL\r\n* Symptomatic splenomegaly\r\n* Enlarging lymph nodes > 2 cm\r\n* Repeated infections requiring oral or i.v. antibiotics
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L within 28 days prior to administration of study treatment.
Within 28 days prior to administration of study treatment: Absolute neutrophil count (ANC) ? 1.5 x 10^9/L
Within 14 days of first dose of study drug: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
Within 14 days of study drug(s) initiation: Absolute neutrophil count (ANC) >=1500/·L.
Within 14 days prior to the first study treatment (cycle 1, day 1): Absolute neutrophil count (ANC) >= 1500 cells/uL.
Within 14 days prior to first dose of study drug treatment: Absolute neutrophil count (ANC) >= 1.5 x 109/L
Measured within 28 days prior to administration of study treatment: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
Obtained within 14 days (or as stipulated) prior to study drug (treatment) administration: absolute neutrophil count (ANC) ? 1000 cells/ul (growth factor cannot be used within the previous 5 days)
Absolute neutrophil count (ANC) >= 1500/uL, specimens must be collected within 10 days prior to the start of study treatment
Absolute neutrophil count (ANC) ? 1.0 × 109/L within 14 days prior to randomization
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L, measured within 28 days prior to administration of study treatment
Absolute neutrophil count (ANC) < 750/uL, if these cytopenias are not judged by the investigator to be due to underlying disease (i.e. potentially reversible with anti-neoplastic therapy)
Absolute neutrophil count (ANC) must be > 750/mm^3 (unless due to underlying disease in which case there is no grade restriction)
Within 14 days of study start: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
Absolute neutrophil count (ANC) >= 1.5 x 10^9 (SI units 10^9/L)
Prior to cyclophosphamide and T cell infusions: absolute neutrophil count (ANC) =< 1000
Within 14 days prior to the first study treatment (cycle 1, day 1): Absolute neutrophil count (ANC) >= 1500 cells/uL
Absolute Neutrophil Count (ANC) <1000 within 8 weeks prior to initial cryoablation procedure.
Within 30 days prior to initiation of protocol treatment: Absolute neutrophil count (ANC) >= 1500/mm^3
Obtained within 14 days prior to the first study treatment (cycle 1, day 1); absolute neutrophil count (ANC) ? 1500 cells/uL
Absolute neutrophil count (ANC) >= 1500/mcl (filgrastim [G-CSF] is allowed) (must be within 7 days of MLA)
Absolute neutrophil (segmented and bands) count (ANC) >= 1.0 x 10^9/L
Absolute neutrophil count (ANC) >= 1,500/ul (unless due to bone marrow infiltration by tumor in which case ANC >= 500/ml are allowed)
Absolute neutrophil (segmented and bands) count (ANC) >= 1.0 x 10^9/L
Absolute neutrophil count (ANC, calculated as the absolute number of neutrophils and bands) >= 1.5 x 10^9 cells/L
Absolute neutrophil count (ANC) >= 1500 cells/uL (obtained within 14 days prior to the first study treatment [course 1, day 1])
Absolute neutrophil count (ANC) of >= 1,500/microliters within 90 days prior to registration
Absolute neutrophil count (ANC) > 1000 unless impairment due to organ involvement by lymphoma
Absolute neutrophil count (ANC) must be > 750/mm^3 (unless due to underlying disease in which case there is no grade restriction)
Within 14 days prior to first study treatment: Absolute neutrophil count (ANC) >= 1500/10^9 dL
Absolute neutrophil count (ANC) > 1,500 cells/ul within 14 days prior to treatment initiation
Patients must have absolute neutrophil count (ANC) >= 1000/uL; Neupogen can be given prior to start of SGN-35 (brentuximab vedotin) and during SGN-35 treatment to achieve target ANC >= 1000/uL
Absolute neutrophil count (ANC) < 1,000/mm^3 (International System of Units [SI] units 109/L)
Absolute neutrophil count (ANC) >= 1,500 cells/mm^3 (International System of Units [SI] units 1.5 x 10^9/L)
Absolute neutrophil count (ANC) >= 1500 cells/uL (obtained within 28 days prior to the first study treatment)
Patients with absolute neutrophil count (ANC) >= 1,000/uL; the most recent ANC level taken within 60 days prior to study enrollment will be considered
Subjects with an absolute neutrophil count (ANC) of equal to or higher than 0.5 x 10^9/L at the screening visit
Absolute neutrophil count (ANC) >= 1500, unless felt to be secondary to underlying mantle cell lymphoma
Anticipated or documented prolonged neutropenia (absolute neutrophil count [ANC] < 500/mm^3 [0.5 x 10^9/L]) at baseline or likely to develop within 3 to 5 days and lasting for at least 7 days due to:
Patients must have or be anticipated to have neutropenia (absolute neutrophil count [ANC] < 0.5 x 10^9/L) (75) for >= 7 days as a result of treatment of their AML/MDS
Absolute neutrophil count (ANC) >= 1,500/uL, obtained within 14 days prior to treatment start
Measured within 28 days prior to administration of study treatment: Absolute neutrophil count (ANC) >= 1.5 x 10^9/L
Absolute neutrophil count (ANC) >= 1.5 X 10^9/L (evaluated within 28 days of\r\nrandomization)
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L, within 2 weeks prior to study start
Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days prior to step 2 randomization
Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcl documented within 28 days prior to step 1 registration
Absolute neutrophil count (ANC) >= 750/mcl within 28 days prior to registration
absolute neutrophil count (ANC) ?1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
SAFETY RUN-IN: Within 10 days of registration: Absolute neutrophil count (ANC) >= 1,500 /mcL
RANDOMIZED PHASE II CLINICAL TRIAL: Within 10 days of registration: Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) < 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL.
Within 14 days of treatment registration: Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) > 1000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 28 days of study registration
Absolute neutrophil count (ANC): >= 1500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 750/mcL; a subject will not be excluded because of pancytopenia related to disease
Absolute neutrophil count (ANC) >= 1,500/mcL
Within 28 days of cycle 1 day 1: Absolute neutrophil count (ANC)\t>= 1,000/mcL
Within 5 days prior to the start of study treatment: Absolute neutrophil count (ANC) >= 1,500 /mcL.
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL.
Absolute neutrophil count (ANC) >= 1.5 k/mcl, obtained within 7 days prior to first study treatment
Absolute neutrophil count (ANC) >= 1,500 /mcL.
Within 7 days of registration: Absolute neutrophil count (ANC) >= 1,500/mcL
Within 10 days prior to on-study date: Absolute neutrophil count (ANC) ? 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 750 /mcL
Absolute neutrophil count (ANC) ? 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/ mcL
Absolute neutrophil count (ANC) >= 1,000 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Obtained within 14 days prior to enrollment: absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1500/mcL, performed within 14 days of protocol registration
Absolute neutrophil count (ANC) > 1000/mcL
Absolute neutrophil count (ANC) >= 500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 14 days of registration
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL.
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL, during screening and on cycle 1, day 1
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC): >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days prior to registration
Absolute neutrophil count (ANC) > 500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Performed 28 days prior to study registration up to the first dose of study drug: absolute neutrophil count (ANC) >= 1,000 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) < 1000/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
PHASE I: Absolute neutrophil count (ANC) > 1,500/mcl
PHASE II: Absolute neutrophil count (ANC) > 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL except in cases of marrow infiltration by lymphoma
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Performed within 28 days prior to study registration up to the first dose of study drug: Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,250/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Newly diagnosed MCL: Absolute neutrophil count (ANC) > 750/mm^3; patients who have bone marrow infiltration by MCL are eligible if their ANC is equal to or > than 500
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) < 1000/mcL
Patients must have absolute neutrophil count (ANC) > 1000/mcl
Absolute neutrophil count (ANC) ? 1,000/mcL OR ? 750/mcL if neutropenia due to iBCL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500 /mcL
REGISTRATION TO TREATMENT (STEP 1): Absolute neutrophil count (ANC) >= 1,500 /mcL, within 14 days prior to first dose of pembrolizumab
REGISTRATION TO TREATMENT (STEP 2): Absolute neutrophil count (ANC) >= 1,500 /mcL, within 14 days prior to first dose of pembrolizumab
Absolute neutrophil count (ANC) >= 1500 /mcL
Absolute neutrophil count (ANC) ? 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >=1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Within 14 days of registration: Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000 cells/mcL within 42 days prior to registration
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) < 1.0 K/mcL at time of enrollment
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcL (ANC >= 1.5 x 10^9/liter [L])
Within 14 days prior to registration: Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,000/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 14 days prior to registration
Performed within 28 days of radiation therapy: Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) > 1000/mcL
Absolute neutrophil count (ANC) >= 1.5 K/mcL
Absolute neutrophil count (ANC) > 1500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1500/mcL
Absolute Neutrophil Count (ANC) ? 1,500/mcL
Absolute neutrophil count (ANC) of at least 2000 per mcL
Absolute neutrophil count (ANC) count greater than or equal to 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) < 1000/mcl
An absolute neutrophil count (ANC) >= 1,500/mcl
Absolute neutrophil count (ANC) > 1500/mcl
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) > 750 cells/mcl
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl
Absolute neutrophil count (ANC) < 1.5 K/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) < 1.0 K/mcL
At the discretion of the operating surgeon, absolute neutrophil count (ANC) > 1000/mcl
Absolute neutrophil count (ANC) < 1.0 K/mcL
At the discretion of the physician, absolute neutrophil count (ANC) > 1000/mcl
Absolute neutrophil count (ANC) < 1.0 K/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of protocol enrollment
Absolute neutrophil count (ANC) >= 1,500 /mcL
Human immunodeficiency virus (HIV) positive with CD4 count < (350) cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= (350) cells/microliter, and no known detectable viral load, at the time of study entry; note also that HIV testing is not required for eligibility for this protocol
Human immunodeficiency virus (HIV) positive with cluster of differentiation 4 (CD4) count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to step 1 registration; note also that HIV testing is not required for eligibility for this protocol
Known human immunodeficiency virus (HIV) positive with CD4 count < 200 cells/microliter. Note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol; this exclusion criterion is necessary because the treatments involved in this protocol may be significantly immunosuppressive.
Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol
HIV positive with CD4 count < 200 cells/microliter within 30 days prior to registration
HIV patients under treatment with highly active antiretroviral therapy (HAART) within 30 days prior to registration regardless of CD4 count; (Note: HIV testing is not required for eligibility for this protocol as it is self-reported; this exclusion criterion is necessary because the treatments involved in this protocol may be immunosuppressive and/or interact with HAART)
Severe, active co-morbidity defined as follows: \r\n* Human immunodeficiency virus (HIV) positive with CD4 count < 200 cells/microliter; Note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; Note also that HIV testing is not required for eligibility for this protocol\r\n* Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; note, however, that laboratory tests for liver function and coagulation parameters are not required for entry into this protocol; (patients on Coumadin or other blood thinning agents are eligible for this study)
Major medical illnesses or psychiatric impairments, which in the investigators opinion, will prevent administration or completion of the protocol therapy and/or preclude informed consent; these include, but are not restricted to:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization at the time of step 2 registration\r\n* Transmural myocardial infarction within the last 6 months prior to step 2 registration\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of step 2 registration\r\n* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of step 2 registration\r\n* Type II neurofibromatosis (NF2)\r\n* Ailments entailing substantial increases in sensitivity and side effect risk from radiation therapy (ataxia telangiectasia, Nijmegen breakage syndrome, and human immunodeficiency virus (HIV) with CD4 count < 200 cells/microliter); HIV testing is not required for eligibility for this protocol, and known HIV positive patients are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to step 2 registration\r\n* Inability to undergo MRI with and without contrast (e.g. claustrophobia, non-MRI compatible implant or foreign body, etc) or receive gadolinium; note that patients with severe claustrophobia are permitted on this study if they are willing and able to undergo MRI with adequate sedation or anesthesia
Patients who are human immunodeficiency virus (HIV) positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a cluster of differentiation (CD)4 count >= 200 cells/microliter within 180 days prior to registration as documented in the medical record; HIV testing is not required for eligibility for this protocol
Severe, active comorbidity, defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months\r\n* Transmural myocardial infarction within the last 6 months\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects\r\n* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration\r\n* Uncontrolled, clinically significant cardiac arrhythmias\r\n* Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count < 200 cells/microliter\r\n** Note: patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to Step 1 registration\r\n** Note: HIV testing is not required for eligibility for this protocol
Severe, active co-morbidity, defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months prior to registration;\r\n* Transmural myocardial infarction within the last 6 months prior to registration;\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration;\r\n* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy within 30 days prior to registration;\r\n* Severe hepatic disease, defined as a diagnosis of Child-Pugh class B or C hepatic disease if the liver is involved with metastatic disease;\r\n* Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol
Severe, active co-morbidity, defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last six months\r\n* Transmural myocardial infarction within the last six months\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Chronic obstructive pulmonary disease exacerbation or other chronic respiratory illness requiring hospitalization within the last six months\r\n* Human immunodeficiency virus (HIV)-positivity with cluster of differentiation (CD)4 count < 200 cells/microliter; Note that HIV-positive patients are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter no more than 30 days prior to registration; Note also that HIV testing is not required for eligibility on this protocol\r\n* End-stage renal disease (i.e., any patient requiring or advised to undergo dialysis)
HIV positive with CD4 count < 200 cells/microliter; note that patients who are human immunodeficiency virus (HIV) positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter prior to registration; note also that HIV testing is not required for eligibility for this protocol
Severe, active co-morbidity, defined as follows:\r\n* Diagnosis of type I or type II diabetes mellitus\r\n* Uncontrolled neuropathy >= grade 2 regardless of cause\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months\r\n* Transmural myocardial infarction within the last 6 months\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy within 30 days of registration\r\n* Severe hepatic disease, defined as a diagnosis of Child-Pugh class B or C hepatic disease\r\n* Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol\r\n* End-stage renal disease (ie, on dialysis or dialysis has been recommended)
Severe, active co-morbidity, defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months\r\n* Transmural myocardial infarction within the last 6 months\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of step 1 registration\r\n* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of step 1 registration\r\n* Severe hepatic disease, defined as a diagnosis of Child-Pugh class B or C hepatic disease\r\n* Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol\r\n* End-stage renal disease (ie, on dialysis or dialysis has been recommended)
Severe, active co-morbidity, defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months prior to registration\r\n* Transmural myocardial infarction within the last 6 months prior to registration\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy within 30 days prior to registration\r\n* Severe hepatic disease, defined as a diagnosis of Child-Pugh class B or C hepatic disease\r\n* Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD) 4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol\r\n* End-stage renal disease (i.e., on dialysis or dialysis has been recommended)
Severe, active co-morbidity defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months\r\n* Transmural myocardial infarction within the last 6 months\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Severe hepatic disease, defined as a diagnosis of Child-Pugh class B or C hepatic disease\r\n* Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol\r\n* Other major medical illness which requires hospitalization or precludes study therapy at the time of registration
Severe, active co-morbidity, defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months\r\n* Transmural myocardial infarction within the last 6 months\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy within 30 days before registration\r\n* Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; note also that HIV testing is not required for eligibility for this protocol\r\n* End-stage renal disease (i.e., on dialysis or dialysis has been recommended)
Severe, active co-morbidity defined as follows:\r\n* Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months\r\n* Transmural myocardial infarction within the last 6 months\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Chronic obstructive pulmonary disease exacerbation or other acute respiratory illness precluding study therapy at the time of registration\r\n* Severe hepatic disease defined as a diagnosis of Child-Pugh class B or C hepatic disease\r\n* Renal tubular acidosis or metabolic acidosis\r\n* Human immunodeficiency virus (HIV) positive with CD4 count < 200 cells/microliter; note that patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter within 30 days prior to registration; Note also that HIV testing is not required for eligibility for this protocol
* Platelets >= 100 x 10^9 cells/ L (unsupported, defined as no platelet transfusion within 7 days)
Hemoglobin >= 8g/dl (unsupported)
ANC > 1,500/µl (unsupported by growth factors) and
Absolute neutrophil count >= 1000/ mm^3 (unsupported) and documented within 14 days prior to registration and within 14 days prior to the start of treatment
Platelets >= 100,000/ mm^3 (unsupported) and documented within 14 days prior to registration and within 14 days prior to the start of treatment
Documented within 14 days of registration: Absolute neutrophil count >= 1000/ul (unsupported)
Documented within 14 days of registration: Platelets >= 75,000/ul (unsupported)
Platelets >= 75,000 cells /uL (unsupported, defined as no platelet transfusion within 7 days)
INCLUSION CRITERIA FOR STRATUM C: Platelets >= 75,000 cells/uL (unsupported, defined as no platelet transfusion within 7 days)
Absolute neutrophil count >= 1,000/uL (unsupported), within 14 days of registration and within 7 days of the start of treatment
Platelets >= 100,000/L (unsupported), within 14 days of registration and within 7 days of the start of treatment
Platelets >= 100,000/ul (unsupported)
Platelets >= 80,000 x 10^9/L unsupported by transfusions (within 14 days of study registration)
Hemoglobin >= 9 g/dL, unsupported by transfusions (within 14 days of study registration)
Platelets >= 100 x 10^9 cells/L (unsupported, defined as no platelet transfusion within 7 days)
Platelets >= 80,000 x 10^9/L, unsupported by transfusions
Hemoglobin >= 9 g/dL, unsupported by transfusions
Absolute neutrophil count (ANC) >= 1000 x 10^9/L, unsupported by filgrastim (G-CSF) or granulocytes
Within 14 days of registration: Platelets >= 100,000/mcL unsupported by transfusions
Platelets ? 75,000/mm3 (unsupported for 7 days)
Hemoglobin ? 9g/dl (unsupported) for 7 days
Platelets >= 100,000/mm^3 (unsupported, defined as no platelet transfusion within 7 days and recovery from nadir)
Platelets >= 100,000/ul (unsupported)
Hemoglobin (Hg) >= 8g/dL (unsupported)
Absolute neutrophil count >= 1,000/mm^3 (unsupported)
Platelet count >= 100,000/mm^3 (unsupported)
Absolute neutrophil count >= 1,000/mm^3 (unsupported)
Platelet count >= 75,000/mm^3 (unsupported)
Adequate bone marrow function (hemoglobin ? 9.0 g/dL; unsupported platelets ? 100×109 cells/L; absolute neutrophil count [ANC] ? 1.5×109 cells/L without the use of hematopoietic growth factors)
Adequate bone marrow function (hemoglobin ? 9.0 g/dL; unsupported platelets ? 100 x10 9 cells/L; absolute neutrophil count ? 1.5x10 9 cells/L
Hemoglobin >= 9 g/dL unsupported by transfusions within 7 days
Platelets >= 100,000/mm^3 (unsupported)
Hemoglobin >= 10 g/dL (unsupported)
Absolute neutrophil count (ANC) ? 500/?l and platelets ? 20000/?l (unsupported by transfusions).
Within 14 days of treatment initiation: Absolute neutrophil count >= 1,500/mcL
Within 21 days of treatment initiation:\r\nAbsolute neutrophil count (ANC) >= 1,500/mcL
Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL (up to 14 days before treatment initiation)
Within 14 days of treatment initiation:\r\nAbsolute neutrophil count (ANC) >= 1,500 /mcL
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,000 /mcL
Absolute neutrophil count (ANC) >= 1500/mcL, performed within 10 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 14 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,000/mm^3, performed within 14 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 10 days of treatment initiation
Within 2 weeks prior to initiation of study treatment: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 14 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500 /mcL within 14 days of treatment initiation
Absolute neutrophil count >= 1000/mm^3 (performed within 14 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1,000/mcL (performed within 28 days of treatment initiation)
Should be performed within 10 days of treatment initiation: absolute neutrophil count (ANC) ? 1.5 x 10^9/L (?1500 per mm^3)
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 28 days of treatment initiation
Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) ? 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL, should be performed within 10 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment
Absolute neutrophil count (ANC) ? 1,500 /mcL within 21 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,000/mcL within 21 days of treatment initiation
Performed within 10 days of treatment initiation: absolute neutrophil count (ANC) >= 1,500 /mcL
Should be performed within 30 days of treatment initiation: absolute neutrophil count (ANC) ? 1,000 /mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL (performed within 10 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 14 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 28 days of treatment initiation
To be performed within 14 days of treatment initiation: absolute neutrophil count (ANC) ? 1,500 /mcL
Absolute neutrophil count (ANC) ? 1,000 /mcL within 14 days of treatment initiation
Absolute neutrophil count >= 1,500/mcL within 14 days of treatment initiation
Within 10 days of treatment initiation: Absolute neutrophil count >= 1500/mcL.
Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1000/mcL
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) ? 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL (performed within 10 days of treatment initiation)
Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,000 /mcL, performed within 10 days of treatment initiation
Performed within 7 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Performed within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count (ANC) >= 1,000/mcL, performed within 14 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,000/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days of treatment initiation
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 500 /mcL performed within 10 days of treatment initiation
Absolute neutrophil count (ANC) >=1,500 /mcL (within 10-15 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1,000/mcL within 16 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,000 /mcL (performed within 10 days of treatment initiation)
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Completed within 10 days of SBRT treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL within 14 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,000 /mcL, performed within 10 days of treatment initiation
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
Absolute neutrophil count (ANC) >= 1500/mcL (within 28 days of treatment initiation)
Performed within 14 days (+3 working days) of treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
Performed within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 10 days of treatment initiation
Performed within 10 days of treatment initiation; absolute neutrophil count (ANC) ? 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL, should be performed within 10 days of treatment initiation
Absolute neutrophil count (ANC) ? 1000 /mcL within 7 days of treatment initiation
All screening labs should be performed within 14 days (+3 working days) of treatment initiation: absolute neutrophil count (ANC) >= 1,500 /mcL;
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1.5 x 109/L
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 28 days of treatment initiation
Within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL without growth factors within 2 week of initiation of treatment
Absolute neutrophil count (ANC) >= 1,500/mcL (performed within 10 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1,500/mcL, OR >= 1,000/mcL if lymphomatous bone marrow involvement, performed within 10 days of treatment initiation
Within 30 days prior to treatment initiation: Absolute neutrophil count (ANC) >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000 /mcL (performed within 10 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500/mcL (within 14 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1.5 K/mcL, should be performed within 28 days of treatment initiation, unless otherwise indicated
Absolute neutrophil count (ANC) >= 1.0 x 10^9/L, performed within 28 days of treatment initiation
Within 14 days of treatment initiation: Absolute neutrophil count (ANC) >= 1,500 /mcL
Absolute neutrophil count (ANC) >= 1,500/mcL, performed within 28 days of treatment initiation
Absolute neutrophil count >= 1,500/mcL (labs should be performed within 14 days of treatment initiation)
Absolute neutrophil count (ANC) >= 1,500/mcL within 7 days of treatment initiation
Performed within 10 days of treatment initiation: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,000/mcL, within 14 days prior to initiation of study drug
Performed within 10 days of treatment initiation: Absolute neutrophil count (ANC) >= 1500/mcL
Absolute neutrophil count (ANC) >= 1,500/mcL (performed within 10 days of treatment initiation)
Obtained within 14 days prior to initiation of treatment: Absolute neutrophil count >= 1,500/mcL
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
Absolute neutrophil count (ANC) >= 1,500 /mcL, performed within 10 days of treatment initiation
